A detailed history of Pathstone Holdings, LLC transactions in Organon & Co. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 38,792 shares of OGN stock, worth $692,437. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,792
Previous 37,751 2.76%
Holding current value
$692,437
Previous $709,000 13.12%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$17.45 - $21.96 $18,165 - $22,860
1,041 Added 2.76%
38,792 $802,000
Q1 2024

May 13, 2024

BUY
$13.78 - $18.8 $82,996 - $113,232
6,023 Added 18.98%
37,751 $709,000
Q4 2023

Feb 14, 2024

BUY
$10.95 - $17.32 $347,421 - $549,528
31,728 New
31,728 $457,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.54B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.